These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 29398639

  • 1. Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
    Gupta MK, Chandra A, Prakash P, Tilak R.
    J Mycol Med; 2018 Mar; 28(1):201-205. PubMed ID: 29398639
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW, Ruiz J, Chidambaram JD, Maxey KJ, Hong KC, McLeod SD, Lietman TM.
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ, Lalitha P, Prajna NV, Karpagam R, Geetha M, O'Brien KS, Oldenburg CE, Ray KJ, McLeod SD, Acharya NR, Lietman TM, Mycotic Ulcer Treatment Trial Group.
    Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against Fusarium Species Ocular Isolates.
    Rees CA, Bao R, Zegans ME, Cramer RA.
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010869
    [Abstract] [Full Text] [Related]

  • 12. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y, Pang GR, Zhao DQ, Gao CW, Zhou LT, Sun ST, Wang BL, Chen ZJ.
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
    Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T, Mascarenhas J, Vaitilingam CM, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM.
    Cornea; 2012 Jun; 31(6):662-7. PubMed ID: 22333662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.
    Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X.
    Am J Ophthalmol; 2008 Aug; 146(2):260-265. PubMed ID: 18547535
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Arora R, Gupta D, Goyal J, Kaur R.
    Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.